New research aims to help lessen the risk of opioid misuse and overdose

FHS
July 15, 2024
4:30 pm

New research aims to help reduce the quantity of unused prescription opioids after emergency department visits and lessen the risk of opioid misuse and overdose.

PSMA PET Beats MRI in Prostate Cancer Staging Study

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II

July 3, 2024

Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia – Biotech Investments

Biophytis / Key word(s): Miscellaneous Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia 11-Sep-2023 / 07:00 CET/CEST Biophytis obtains

September 12, 2023

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates | Psychedelic Invest

NEW YORK and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.